NCT04497480

Brief Summary

Most previous clinical trials that addressed the rehabilitation training system for sarcopenic elderly subjects focused on community-dwelling older adults who were relatively healthy. There is a notable paucity of high-quality research investigating the effects and feasibility of the device for hospitalized or institutionalized older people, who are generally frailer and more severe in functional impairment than those living in the community. Moreover, most reported the system were of long-term duration, which typically lasted 3 to 6 months with two sessions per week. It remains unclear whether short-term the device training would be effective for treating sarcopenia. Therefore, the investigators aimed to assess the effectiveness of Motor-Assisted and Active Resistive Upper/Lower Extremities Rehabilitation Training System for treating sarcopenia in hospitalized older patients aged 80 years and over.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 29, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 4, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

1.2 years

First QC Date

July 29, 2020

Last Update Submit

September 13, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change of activities of daily living

    Basic activities of daily living (BADL) assessed by Barthel Index

    3 Months

Secondary Outcomes (1)

  • The change of handgrip strength

    3 months

Study Arms (2)

experimental group

EXPERIMENTAL
Behavioral: Motor-Assisted and Active Resistive Upper/Lower Extremities Rehabilitation Training System

controlled group

NO INTERVENTION

Interventions

The Passive, Motor-Assisted and Active Resistive Upper/Lower Extremities Rehabilitation Training System is designed for patients confined to bed at the long-term care facilities hospitals, in early rehabilitation. This system can induce a natural movements of the upper/lower limb with safe motorized passive movement, as well as motor-assisted and active resistive muscle training to stimulate nerves, increase blood circulation of affected tissue, cell metabolism and improve joint mobility, in promoting upper/lower extremities motor recovery.

experimental group

Eligibility Criteria

Age80 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Sarcopenia defined by the Asia Working Group of Sarcopenia (AWGS)
  • Agree to participant this study and sign the informed consent
  • Aged 80 years or over

You may not qualify if:

  • Patients who could not follow the training plan due to cognitive impairment, emotional problems or any other reasons;
  • Severe heart and lung diseases;
  • Renal insufficiency;
  • Any type of tumor;
  • Bedridden patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital,Sichuan University

Chengdu, Sichuan, 610064, China

RECRUITING

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

July 29, 2020

First Posted

August 4, 2020

Study Start

July 28, 2020

Primary Completion

October 1, 2021

Study Completion

December 1, 2021

Last Updated

September 14, 2021

Record last verified: 2021-09

Locations